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Summary.-The weights of osteosarcomata that arose 22 days after the s.c. injection
of cell suspensions (of whole tumours) that had been exposed in vitro to tRNA were
significantly different from the weights of those arising from untreated cells. The
tRNA was isolated by phenol extraction and DEAE-cellulose chromatography
from eviscerated full-term rat embryos, from rat mesenchymal (granulation)
tissue and from rat anaplastic osteosarcomata. Tumours developing from osteo-
sarcoma cells treated with either embryonic or normal mesenchymal tRNA were
reduced in weight by76% and600 respectively. These effects could not be explained
as a toxic consequence, because tumour weight was increased by 128% after ex-
posure of cells to osteosarcoma tRNA. In this osteosarcoma model it appears
that tumour weights can be influenced in different ways by tRNA from different
sources.
IT IS KNOWN that tumour and other
cells can effectively take up transfer
ribonucleic acids (tRNA) in vitro, and
that an appreciable percentage of this
retains its polymeric form for some hours
and remains functional, i.e., able to
accept amino acids (Herrera, Adamson
and Gallo, 1970; Busch et al., 1972;
Volkin et al., 1973).
In view of reports of differences either
in the amount of one isoaccepting tRNA
species or in the number of isoaccepting
species in various tissues during embryo-
genesis (Taylor et al., 1971) and regenera-
tion (Agarwal, Hanoune and WTeinstein,
1970) or oncogenesis (Baliga et al., 1969),
it is conceivable that changes in tRNA
may be crucial for maintaining a cell
in a particular state of differentiation.
Several workers have reported that
the addition to tumour cells of exogenous
RNA, extracted from normal tissues,
could inhibit their growth (De Carvallo
and Rand, 1961; Niu, Cordova and Niu,
1961; Aksenova et al., 1962). Recent
investigations of uptake of RNA have
shown that recipient cells preferentially
take up tRNA (Volkin et al., 1973) and
that the degree of degradation of 4S RNA
is less than that of the other types of
RNA studied (Okada and Busch, 1972).
It therefore seems possible that tRNA
is the sole causative agent of such docu-
mented effects of exogenous RNA. The
present work was undertaken to investi-
gate the effect ofthe addition ofexogenous
tRNA to cell suspensions of osteosarco-
mata on their subsequent growth.
Granulation tissue was selected as
a source of normal mesenchymal tRNA,
because it provided this nucleic acid in
quantity without the technical problems
associated with the use of muscle or
bone. Embryonic tRNA was used because
of the revived interest in the concept of
depression, in neoplasia, of genes that
normally function only in the embryonic
tissue of origin and because embryonic-
like tRNA species have been found in
malignant cells (Yang, 1971; Gonano,INFLUENCE OF tRNA ON OSTEOSARCOMATA
Pirro and Silvetti, 1973). Transfer RNA
derived from anaplastic osteosarcomata
was used to determine whether or not
a " double dose " of the tRNA species
present in the tumour cells would enhance
growth.
MATERIALS AND METHODS
Sources of tRNA.-Transfer RNA was
isolated and purified from rat embryonic
tissue, from normal rat mesenchymal tissue
and from a rat non-bone-forming osteo-
sarcoma. The full-term embryos were evis-
cerated to ensure the greatest yield ofmesen-
chymal tRNA. The mesenchymal tissue
was obtained from granuloma pouches,
produced by a 0-1 ml injection of 1% croton
oil suspended in corn oil (Selye, 1953).
Tumours.-Osteosarcomata were of the
20th to 41st transplant generations of a
tumour induced in an inbred DA rat by 32p
as previously described (Geddes-Dwyer et
al., 1974). They were non-calcifying, very
cellular with a minimum of matrix, and
transplanted at 3-4 week intervals depending
on experimental requirements.
Preparation of tRNA.-The following
precautions were taken to reduce the possi-
bility of degradation of tRNA during
preparation. (a) Because ribonuclease has
a high affinity for glass (Hummel and
Anderson, 1956) all glassware was cleaned,
either with 30% hydrogen peroxide, or
when size permitted, by steam sterilization.
(b) Polyethylene gloves were worn during
all procedures. (c) After rapid aseptic
removal, tissue was dropped immediately
into liquid air. (d) Analytical reagents only
were used and unless otherwise mentioned,
all isolation and purification procedures
were performed at a constant pH of 7-5
at 40C.
(i) Extraction of tRNA
Twenty g of frozen tissue was homo-
genized in a Waring Blender for 10min
with 30 ml of 10-M NaCl, 0-005M
EDTA in 0-1 M Tris-chloride buffer at
pH 7-5 and 30 ml phenol saturated with
this solution. The homogenate was centri-
fuged for 20 min at 5000g. The aqueous
phase was removed with a sterile pipette,
mixed with an equal amount of buffer-
saturated phenol, and re-centrifuged as
above. The aqueous layer was carefully
pipetted off. Three volumes of95% ethanol
containing 2% potassium acetate were added
to it and any DNA present was spooled out
as a rapidly forming precipitate. After
a minimum of 2 h at -20°C the nucleic
acid flocculated in the remaining aqueous
layer/ethanol solution.
(ii) DEAE-cellulose chromatography
The tRNA was further purified by
ion-exchange chromatography (Holley et al.,
1961). The sample to be chromatographed
was dissolved in 0u1 M Tris-buffer and
applied to a squat DEAE-cellulose column
(8 cm) (Whatman DE-23) with a diameter
of 2 cm. All contaminating polysaccharides
and neutral proteins were washed off with
1-5 1 of 0-1 M Tris-buffer at pH 7-5. Step-
wise elution was then performed using
0-25 M, 0-6 M, I M and 2 M NaCl in 0-2 M
Tris-buffer (pH 7.5). UV analysis was
carried out on the eluted samples and
fractions containing the tRNA, which elutes
at 0-6 M NaCl (Fig. 1), were precipitated
with 95% ethanol/2% potassium acetate and
left overnight at -20°C to flocculate maxim-
ally. The precipitate was spun down and
washed first in 80% ethanol and then twice
in 95% and lyophilized. The concentration
of tRNA was estimated on the basis of
one optical density unit at 260 nm being
equivalent to 45 jug (Hotchkiss, 1975). The
yield of tRNA was approximately 0-5 mg/g
of tissue extracted.
Gel electrophoresis oflyophilizedfraction.-
This was carried out on both 12% and
7% acrylamide/0-35% bisacrylamide at 50 V
and 3 mA per gel for 6 h in 0-12 M Tris/0-05
M NaAc/0-003 M EDTA at pH 7-8. E.
coli RNAs were used as markers in order
to establish the sedimentation velocity ofthis
fraction.
Assay of tRNA amino acid-accepting
activity.-Both the preparation of amino-
acyl synthetase and the assay were performed
according to the methods described by Gallo
and Pestka (1970) with the following minor
modifications: (i) tRNA was removed from
all amino-acyl tRNA synthetase prepara-
tions by precipitation with 5% streptomycin
sulphate; (ii) endogenous amino acids were
removed by Sephadex G25 chromatography;
(iii) protein hydrolysate - 14C (Amersham)
with a specific activity of 57 ,uCi/milli-atom
carbon was used as a source of uniformly
labelled amino acids in the assay; (iv) the
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precipitates, after being washed with 5%
trichloracetic acid and dried with an infra-red
lamp on the HA Millipore filters were counted
in a scintillant cocktail (toluene: PPO:
POPOP: 100 ml: 400 mg: 2 mg). Counting
on filters was checked by the oxygen flask
combustion method (Kalberer and Rutch-
mann, 1961) and comparable results were
obtained.
Preparation and treatment of cells.-Cells
that were to be exposed to the tRNA were
separated enzymatically with pronase (2
mg/ml, Calbiochem) and DNAase (125 ,ug/ml,
Sigma-DN25). Between 107 and 108 cells/g
of tumour tissue were obtained.
The lyophilized tRNA was dissolved in
Eagle's medium and added at a concentra-
tion of 500 ,ug/ml (Herrera et al., 1970) to
an aliquot of tumour cells (2 x 106 cells/ml)
suspended in Eagle's medium without serum
and buffered with Hepes. This mixture
was left on an orbital shaker at 4°C over-
night. Two controls, one containing Eagle's
medium and cells only and the other con-
taining cells plus degradation products from
RNAase digestion of tRNA, were similarly
treated. In the latter control, tRNA (500
,g/ml) had been incubated with RNAase
(Calbiochem-bovine pancreas, 100 [kg/ml) at
370C for 10 min and the resultant breakdown
products were then added to the aliquot
of tumour cells. Cell numbers or viability
did not drop in either the control or ex.
perimental aliquots after this 15 h incuba-
tion.
The treated and the control cells were
spun down, washed and re-counted. Each
aliquot was subdivided into 0-5 ml quantities
containing 2 x 106 cells for deep s.c. injec-
tion into the flank of syngeneic rats of the
same sex and weight for the control and
experimental series. Between 4 and 8 rats
were used in each experimental series.
After 22 days all animals were killed and
the tumours removed and weighed. Eleven
separate experiments, utilizing freshly pre-
pared tRNA in each instance, were carried
out.
RESULTS
Purity of tRNA preparation
Any mononucleotides or protein con-
taminating the tRNA preparation applied
to the DEAE-cellulose column were
eluted with 0-25 M NaCl in the Tris
buffer (indicated by the first peak in
Fig. 1). The 260/280 ratio (u.v. analysis)
of the tRNA fraction eluted with 0-6 M
NaCl was always >2. No protein was
detected by the Lowry method of estima-
tion. Although there may have been
some protein present, it appeared to have
had no effect, as was shown by the
unaltered behaviour of cells exposed to
the RNAase-treated preparation.
Co-electrophoresis of the lyophilized
fraction with E. coli RNA markers on
the gels showed that the peak obtained
coincided with the 4S RNA of E. coli
(Fig. 2). Electrophoresis on 12% acryl-
amide gels showed that there was no
contamination of the fraction with either
DNA or high molecular weight RNA.
Calculation showed that the tRNA was
functional with approximately 80% of
the preparation aminoacylated.
Effect of exogenous tRNA on tumour
weights
Tumours derived from osteosarcoma
cell suspensions exposed to either the
embryonic or mesenchymal tissue tRNA
weighed less at the end of the 22-day
experimental period (76% and 60% re-
spectively) than those derived from con-
trol cells. Tumours developing from os-
teosarcoma cell suspensions exposed to
tRNA derived from an osteosarcoma
grew much larger (128%) than those
from the cells without such treatment.
Student's t test of all the data for each
treatment showed that the differences
between control and experimental were
significant (Table).
Tumours from osteosarcoma cells ex-
posed to tRNA degraded wvith pancreatic
RNAase were not significantly different in
weight from the weights of tumours
from untreated cells.
DISCUSSION
Interpretation of the many biological
and biochemical effects ascribed to exo-
genous RNA (Bhargava and Shanmugan,
1971) has been made difficult because
total RNA or a mixture of RNAs have
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FIG. 1.-DEAE-cellulose column chromatography at 40C. Dotted line represents molarity of
eluent. 1. Mononucleotides and charged proteins. 2. Peak of tRNA eluting at 0-6 M NaCi.
3. Peak of ribosomal RNA and/or DNA eluting at 2 M NaCl.
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FIG. 2.-Gel electrophoresis on 7% acrylamide/0.35% bisacrylamide of: 1. Lyophilized "tRNA"
fraction. 2. Marker RNAs of E. coli. 3. Co-electrophoresis of 1 and 2 (each sample halved).
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TABLE.-Weight ofTumours at 22 Days
Mean weight tumours±s.e.
,k _
Treatment
A. Embryonic tRNA
Expt. 1
2
3
4
5
Mean
B. Mesenchymal tRNA
Expt. 1
2
3
Mean
C. Osteosarcoma tRNA
Expt. 1
2
3
Mean
Number Control Experi-
of rats (untreated) mental
8
8
8
8
8
40
6
4
8
18
4
8
8
20
6 -02+0-49
1-33±0 09
1 95±05
2 00±0 2
2-86+1 -06
2 -83±0 -45
* % decrease
in weight
2-87+0-07
2-25±0- 15
5-39+0-65
3-85±0-56
* % decrease
in weight
2-68±0-52
1 -67±0-52
1 -99±0-42
2-24±0-27
* % increase
in weight
* % increase or decrease in weight was calculated as (M -Mex)/Mc x 100, where Mc and Mex represent
the mean weight of tumours in control and experimental rats respectively.
been used by many workers. One of
our primary aims therefore, was to obtain
a purified subspecies for use in this
study. Gel electrophoresis failed to cla-
rify whether or not the tRNA preparations
contained 5S RNA as an impurity. No
separate, well-defined peak at 5S was
found on gels, but on several occasions a
broad based 4S peak was obtained. This
could have resulted from heterogeneity
in sizes of tRNA molecules (Friedlander
and Buonassiss, 1970; Taylor et al.,
1971) and we consider that our material
was predominantly tRNA.
Our interpretation of the results is
that the tRNA interacted with the osteo-
sarcoma cells to produce alterations in
tumour weight. However we are aware
that the cell suspensions were derived
from whole tumours. Consequently the
tRNA may have had its effect on non-
tumour cells which in turn may have
influenced the final weights of the tu-
mours.
Any proposed mechanism by which
the in vitro addition of tRNA to the
osteosarcoma cell suspensions results in
alterations in growth is purely conjectural
at present. It is known that both
quantitative and qualitative changes in
tRNA occur in certain physiological and
pathological states. Several workers have
correlated these changes in tRNA with
changes in protein biosynthesis (Lanks
and Weinstein, 1970; Brenner and Ames,
1972) and specific tRNAs may have
regulatory effects, e.g. on cell division
(Ortwerth and Liu, 1973). A simple
explanation of the mechanisms by which
a non-physiological input of tRNA into
tumour cells causes growth alterations
could be based on a competitive-inhibition
role of de-acylated tRNA (Kyner, Zabos
and Levin, 1973). Thus the alterations
t Test
(P)
<0 *001
<0-002
<0*05
<0-001
<0-1
<0 *001
<0*001
<0-05
<0-02
<0-01
<0-1
<0-01
<0*001
<0-001
0-96+0-58
0 54±0 09
0-53±0-38
0-71±0-07
0 73±0 08
0-69±0-13
76%
0 99+0 14
1 -130 02
2-21+0 59
1 56±0-32
60%
6-01±0-7
4-5 +0 39
5-01±0-44
5-11±0-34
128%
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in tumour growth after the treatment
with various tRNAs may reflect a modi-
fication of protein synthesis and cell
phenotype as a consequence of a regula-
tory action, or as a result of competitive
inhibition.
Although the mechanism of action
of the exogenous tRNA is a matter for
speculation, there is no doubt that, when
cell suspensions from our 32P-induced
osteosarcomata were exposed to different
tRNAs, the weights of the resulting
tumours at 22 days were significantly
different.
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